Xanthine oxidase inhibitory peptide capable of improving renal function and application of xanthine oxidase inhibitory peptide

By enzymatically hydrolyzing and purifying processing byproducts of Litopenaeus vannamei, a xanthine oxidase inhibitory peptide, Pro-Leu-Gly-Pro-Pro-Pro, was screened out. This solved the problems of low utilization rate of processing byproducts of Litopenaeus vannamei and side effects of existing uric acid-lowering drugs, and achieved significant effects in lowering uric acid and improving kidney function.

CN120865337APending Publication Date: 2025-10-31OCEAN UNIV OF CHINA +1
View PDF -1 Cites 6 Cited by

Patent Information

Application Number
CN202510964747.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-07-14
Publication Date
2025-10-31

Smart Images

  • Figure CN120865337A_ABST
    Figure CN120865337A_ABST
Patent Text Reader

Abstract

The invention discloses a xanthine oxidase inhibitory peptide with a kidney improving function and application thereof, and belongs to the technical field of biological medicines.The xanthine oxidase inhibitory peptide is screened out by conducting enzymolysis, separation and purification on litopenaeus vannamei processing by-products and utilizing a molecular docking technology, the amino acid sequence of the xanthine oxidase inhibitory peptide is Pro-Leu-Gly-Pro-Pro-Pro, and the amino acid sequence of the xanthine oxidase inhibitory peptide is Pro-Leu-Gly-Pro-Pro-Pro. And the half inhibition concentration of the polypeptide is 2.356 + / -0.2448 mM. The xanthine oxidase inhibitory peptide is proved to have an improvement effect on hyperuricemia mice, the improvement effect is mainly characterized by reducing the content of serum uric acid, creatinine and urea nitrogen of the hyperuricemia mice, inhibiting the activity of xanthine oxidase (XOD) in serum and livers of the mice, inhibiting synthesis of uric acid and improving kidney injury of the mice, and Toxinpred prediction shows that the xanthine oxidase inhibitory peptide has the effect of inhibiting the activity of xanthine oxidase (XOD) in the serum and livers of the mice. The xanthine oxidase inhibitory peptide is free of toxic and side effects, so that the xanthine oxidase inhibitory peptide has a wide application prospect in preparation of food or drugs for improving renal functions.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Cited By

  • Pentapeptide LE5 with xanthine oxidase inhibitory activity and preparation method and application thereof

    CN121574203A

  • Litopenaeus vannamei head umami peptide and preparation method thereof

    CN122060028A

  • XOD inhibitory peptides derived from sheep milk as well as preparation method and application of XOD inhibitory peptides

    CN122171815A

  • A fresh-taste peptide of penaeus vannamei shrimp head hexapeptide, a preparation method and application thereof

    CN122647557A

  • A fresh taste peptide of litopenaeus vannamei shrimp head pentapeptide, a preparation method and application thereof

    CN122668203A